Introduction
Transformation by pp60 v-src causes signi®cant changes in gene expression. Genes activated aberrantly by pp60 v-src determine several of the properties of transformed cells . The importance of gene activation is underscored by the observation that dominant negative mutants for AP-1, STAT3 and members of the Ets family block transformation by v-src, and activated Ha-Ras (Bromberg et al., 1998; Bruder et al., 1992; Granger-Schnarr et al., 1992; Lloyd et al., 1991; Suzuki et al., 1994; Turkson et al., 1998; Wasylyk et al., 1994 ). An essential role for AP-1 has also been demonstrated by the study of ®broblasts isolated from mice nullizygous for the c-Jun gene. Indeed c-jun (7/7) cells expressing vsrc or activated Ha-ras are not transformed in vitro and only cause delayed tumorigenesis in animals. Cells isolated from these tumors have enhanced levels of AP-1 activity caused by the over-expression of JunD but not JunB (Johnson et al., 1996) . Genes repressed by pp60 v-src have also been identi®ed (Inoue et al., 1998; Joseph et al., 1992; Lin et al., 1996; Topol et al., 1997) . Suppression of these genes appear to be important since the ectopic expression of several of them, including SSeCKS, drs and drm, antagonize transformation by v-src and several non nuclear oncogenes (Inoue et al., 1998; Lin and Gelman, 1997; Topol et al., 1997) . Thus an adequate knowledge of cell transformation requires the characterization of the transcription factors and signaling pathways regulated by nonnuclear proteins such as pp60 v-src and activated Ha-Ras. We have previously characterized the constitutive activation of the CEF-4/9E3 chemokine gene in chicken embryo ®broblasts (CEF) transformed by the Rous sarcoma virus (RSV; Bedard et al., 1987a; Cabannes et al., 1997; . CEF-4/ 9E3 encodes a chemokine of the CXC family with extensive amino acid sequence similarity to Interleukin 8 and Gro/MGSA. CEF-4 has chemotactic, angiogenic and weak mitogenic activity indicating a rather pleiotropic action for this cytokine (Martins-Green and Feugate, 1998; Martins-Green and Hanafusa, 1997) . The aberrant expression of CEF-4 is highly correlated with transformation suggesting that pathways regulating the induction of this gene are also important for transformation by pp60 v-src (Bedard et al., 1987a; Sugano et al., 1987) . Constitutive expression of the CEF-4 gene depends on post-transcriptional regulation and on the activation of transcription factors binding to several elements of the CEF-4 promoter (Cabannes et al., 1997; . At least three distinct elements are required for induction by pp60 v-src thus de®ning the v-src responsive unit of the CEF-4 promoter or SRU . One of these elements is a NF-kB binding site identical to the PRDII domain of the human Interferon-b gene. p50NF-kB1 and an IkB-a sensitive protein, which has yet to be identi®ed, interact with PRDII in RSV-transformed CEF (Cabannes et al., 1997) . The SRU also harbors a TPA-responsive element (TRE) bound by JunD/Fra-2 and, to a lesser extent, c-Jun/Fra-2 (our unpublished results). The third element of the SRU is a CAAT box with a consensus binding site for the C/EBP family of transcription factors. In this study, we describe the characterization of the CAAT binding factor. We demonstrate that C/ EBPb binds to this element and contributes to the induction of the CEF-4 promoter in RSV-transformed CEF. In addition, C/EBPb binds to a second site located in proximity of the TRE and this element is also part of the SRU. C/EBPb accumulated in RSVtransformed CEF and was regulated by pp60
v-src at the transcriptional and post-transcriptional levels. By overexpressing a dominant negative mutant, we provide evidence that v-src transformation does not depend on the activation of C/EBPb in CEF cultured in vitro but that C/EBPb is required for the constitutive induction of a subset of the v-src regulated genes including the CEF-4 chemokine.
Results
The CEF-4 SRU contains two C/EBP binding sites
The CAAT box (TAACGCAATT) of the CEF-4 Srcresponsive Unit (SRU) nearly ®ts the consensus sequence for the C/EBP family of transcription factors (TT/GNNGNAATT/G). Moreover, the transfection of an expression vector for avian C/EBPb caused a marked stimulation of the CEF-4 promoter in transient expression assays (our unpublished results). To determine if a C/EBP factor interacts with the CAAT element and regulates the activity of the SRU, we cotransfected plasmid pCDM8-D184 with various constructs of the CEF-4 promoter in NY 72-4RSV infected CEF; these constructs are described in Figure  1a . Plasmid pCDM8-D184 encodes the avian C/EBPb protein (also known as NF-M in birds; Sterneck et al., 1992) devoid of a trans-activating region (KowenzLeutz et al., 1994; Kim et al., 1999) . As shown in Figure 1b , the dominant negative mutant of C/EBPb abolished the v-src dependent activation of a CAT reporter construct controlled by the CEF-4 SRU (plasmid APC/CAT). In contrast, plasmid pCDM8-D184 did not inhibit and in fact stimulated the activity of a TRE-controlled promoter in normal and RSVtransformed CEF (plasmid 3XTRE/CAT).
Recently, we identi®ed a second potential C/EBP binding site located upstream of the TRE. The role of this element, referred to as the distal CAAT box (dCAAT), was investigated with a construct of the CEF-4 promoter harboring a mutation in this element which should disrupt the interaction with C/EBP (mdCAAT/CAT). The activity of this construct was severely reduced in normal and RSV-transformed CEF (Figure 1c) . A similar construct with a mutation in the proximal CAAT box was also less eciently activated by pp60 v-src (mpCAAT/CAT). A mutation in both C/ EBP binding sites completely inactivated the CEF-4 promoter, which was no longer responsive to v-src transformation (m(d+p)CAAT/CAT in Figure 1c ). The activity of these elements was con®rmed with minimal promoter constructs studied in transient expression assays. These constructs consist of two or four copies of the proximal and distal CAAT boxes, respectively, fused to a TATAAAA box and the initiation start site of human b-globin. As shown in Figure 1d , both elements and a similar construct of the TRE were capable of conferring v-src responsiveness to the minimal promoter. Taken together, these results suggest that the proximal and distal CAAT boxes are essential components of the CEF-4 SRU and that they are required for promoter activity in normal and RSVtransformed CEF.
C/EBPb interacts with the CEF-4 CAAT boxes in RSV-transformed CEF
To identify a relevant member of the C/EBP family responsible for the induction of the CEF-4 gene, we screened a cDNA library with a fragment of the avian C/EBPa gene corresponding to the highly conserved DNA binding domain of the protein. Several independent clones were isolated from a library representing mRNA sequences expressed in RSV-transformed CEF. Sequencing analysis of 12 of these clones indicated that C/EBPb was the predominant member represented in the library (nine clones). Two other clones encoded C/ EBPa and one clone was highly similar to mammalian C/EBPd.
Nuclear factors binding to the CAAT boxes of the SRU were investigated by electrophoretic mobility shift assays (EMSA). Speci®c complexes were obtained with the proximal and distal CAAT elements. These complexes were signi®cantly more intense with nuclear extracts of RSV-transformed CEF (lanes 1 and 3 in Figure 2a ; lanes 1 and 6 in Figure 2b ). Similar complexes were formed with a probe corresponding to the NF-M (C/EBPb) binding sites of the cMGF promoter (chicken myelomonocytic growth factor; probe wt NF-M in Figure 2a ). C/EBPb interacts with the cMGF promoter in hematopoietic cell lines (Katz et al., 1993) . The results of competition analysis with an excess of the homologous and mutant version of these oligos were consistent with the notion that a C/ EBP-like factor binds to the proximal and distal CAAT elements in RSV-transformed CEF. Moreover, the CAAT complexes were supershifted or eliminated by a C/EBPb antibody but not with the corresponding pre-immune serum (Figure 2a,b) . These sera did not aect the interaction of AP-1 with the CEF-4 TRE (lanes 20 ± 24 in Figure 2a and data not shown). Therefore, C/EBPb binds to the proximal and distal CAAT boxes of the CEF-4 promoter in CEF. The proximal and distal CAAT complexes are broad and probably consist of more than one band. However, the eect of the C/EBPb antibody indicated that the vast majority of the proximal and distal CAAT complexes contained C/EBPb.
The greater intensity of the CAAT complexes obtained with the RSV-transformed cell extract suggests that pp60 v-src regulates the DNA binding activity and/or expression of C/EBPb. To study this question, we quantitated the level of C/EBPb by Western blotting analysis using total protein extracts of normal and RSV-transformed CEF. As shown in Figure 3a , SR-A RSV transformed CEF had elevated levels of C/EBPb compared to normal, uninfected cells. Using the NIH image program, we determined that the C/EBPb-speci®c bands were four times more intense in samples of RSV-transformed CEF. CEF infected with the transformation de®cient virus, NY315 RSV, did not express the same high level of C/EBPb protein. In these experiments, a positive control was provided by over-expressing C/EBPb with the RCASBP retroviral vector (RCASBP-C/EBPb). Protein loading was monitored with an ERK1 antibody; the expression of ERK1 was not regulated by pp60 v-src in these cells. Interestingly, two bands of roughly 42 and 38 kDa of molecular weight were consistently observed with the C/EBPb antibody. These bands were not detected with the corresponding pre-immune serum indicating that they are both related to C/EBPb. They may represent dierent forms of the protein, as described by others Sears and Sealy, 1992) . However, a band of 20 kDa corresponding to LIP (liver transcriptional inhibitor protein) was never 2 C/EBPb binds to the proximal and distal CAAT boxes of the CEF-4 promoter. (a) EMSA using nuclear extracts from uninfected CEF and CEF infected with SR-A RSV, RCASBP, and RCASBP-C/EBPb retroviruses incubated with the radiolabeled C/EBP consensus probes [proximal CAAT box of CEF-4 promoter (pCAAT; lanes 1 ± 10) and wild type NF-M (wt NF-M lanes 11 ± 19)]. SR-A RSV nuclear extracts bind C/EBP consensus probes with high anity (lanes 3 and 11). Gel supershift analysis using anti-C/EBPb antibody indicates that C/EBPb is a component of the factor responsible for the complex (lanes 5 and 14). EMSA analyses were also performed with the TRE oligonucleotide probe as a control (lanes 20 ± 24). (b) A total of 5 mg of nucleoproteins extracted from uninfected (lanes 1 ± 5) and SR-A RSV transformed CEF (lanes 6 ± 10) were incubated with radiolabeled distal CAAT oligonucleotide probes were analysed by EMSA. Competition assays were performed with excess unlabeled wild type or mutant distal CAAT probes (lanes 2 and 7 respectively). C/EBPb antiserum induces a supershift of the complex formed with both uninfected and SR-A transformed CEF nuclear extracts (lanes 5 and 10) observed in these samples (data not shown but see below). In all samples analysed, the 42 kDa band was predominant.
The transcription of the C/EBPb gene was analysed by run-on transcription assays. As shown in Figure 3b , v-src transformation only had a modest eect on the transcription of this gene. After quantitation in an InstantImager and correction for GAPDH, we concluded that the transcription of the C/EBPb gene was stimulated less than twofold in RSV-transformed CEF (1.8-fold more precisely). The C/EBPa gene was also expressed in these cells, albeit at a very low level, and was not regulated by v-src transformation. In contrast, the transcription of the CEF-4 gene was markedly elevated (10-fold) in RSV-transformed CEF, as reported before (Bedard et al., 1987a; . Using RT ± PCR, we also quantitated the level of the C/EBPb transcript in normal and RSV-infected CEF; again a dierence of less than twofold was observed ( Figure 3c ). Thus pp60 v-src controls the accumulation of the C/EBPb protein at the transcriptional and post-transcriptional levels.
Stable expression of a dominant negative mutant of C/EBPb; effect on v-src dependent gene activation
To study the role of C/EBPb in CEF-4 induction and v-src transformation, we inserted the D184-C/EBPb cDNA in RCASBP retroviral vectors (Petropoulos and Hughes, 1991) . Transfection of the recombinant retroviral DNA led to high expression of the dominant negative mutant of C/EBPb in CEF. As determined by Western blotting analysis, this was true when the D184 C/EBPb insert was cloned into the RCASBP vector encoding an A strain or B strain virus (Figure 4a ). High expression was maintained over several passages indicating that the dominant negative mutant did not inhibit CEF proliferation (our unpublished results). Moreover, D184-C/EBPb was localized predominantly in the nucleus of all cells of the monolayer (Figure 4b ). EMSAs performed with the distal CAAT probe con®rmed the interaction of the protein with its cognate element and the over-expression achieved with the RCASBP vectors (Figure 4a ,c).
We next examined the eect of D184-C/EBPb on the activation of various CEF-4 promoter constructs by pp60 v-src . To this end, CEF infected with the B virus encoding D184-C/EBPb were super-infected with NY72-4 RSV, an A strain virus. Since D184-C/EBPb was expressed in all cells of the monolayer (Figure 4b ), this procedure ensured that all CEF expressing pp60 v-src would also contain the dominant negative mutant of C/EBPb. CEF infected with the parental vector devoid of an insert (RCASBP) were also super-infected with NY72-4 RSV and served as a control in this experiment. As shown in Figure 5a , the v-src dependent activation of the distal CAAT minimal promoter construct was completely suppressed in CEF expressing D184-C/EBPb (46dCAAT/CAT). However, the activation of the CEF-4 promoter or a construct harboring the original CEF-4 SRU was only partly inhibited in the co-infected cells (40 and 25% inhibition for SPE/CAT and APC/CAT, respectively). Therefore, D184-C/EBPb impaired the activity of a promoter controlled exclusively by C/EBPb but did not completely suppress the activation of a promoter regulated by multiple trans-acting factors. Again, a minimal promoter construct controlled by the TRE was not inhibited and was in fact stimulated in the same experiment (36TRE/CAT).
To assess the eect of the dominant negative mutant on the transcription of the endogenous CEF-4 gene, run-on transcription assays were performed on CEF transformed by NY72-4 or SR-A RSV and co-infected with RCASBP-D184-C/EBPb or the control virus, RCASBP(B). As shown in Figure 5b , D184-C/EBPb reduced signi®cantly the transcription of CEF-4 in SR-A RSV-transformed CEF (55% inhibition). In contrast, the dominant negative mutant did not inhibit markedly the activity of two other v-src regulated genes namely Cox-2 and NR-13. Cox-2, originally designated CEF-147 in chicken, is an inducible Prostaglandin Synthase gene (Simmons et al., 1989) while NR-13 encodes an anti-apoptotic member of the Bcl-2 family (Gillet et al., 1995; Mangeney et al., 1996) . Interestingly, transcription of NR-13 was stimulated by the presence of D184-C/EBPb in SR-A RSV-transformed CEF; this will be discussed below. The same results were obtained with CEF co-infected with RCASBP-D184 C/EBPb and NY72-4 RSV at the permissive temperature (data not shown).
We then characterized the accumulation of the CEF-4, Cox-2 and NR-13 mRNAs in cells co-infected with tsNY72-4 RSV and D184-C/EBPb or the parental, control vector RCASBP(B). As shown in Figure 6 , the expression of the CEF-4 transcript was reduced in the presence of the dominant negative mutant of C/EBPb. This was true for cells transferred to the permissive In RSV-transformed CEF, Cox-2 is regulated at the transcriptional level and at the level of splicing. Normal cells express an unspliced precursor transcript which is then processed into the mature Cox-2 mRNA upon ts pp60 v-src activation (Xie et al., 1991) . Interestingly, a reduction in the level of the Cox-2 precursor mRNA was observed at all time points after temperature shift in cells expressing D184-C/EBPb. In contrast, no reduction in the expression of NR-13 was caused by the dominant negative mutant. In fact, we consistently observed a greater accumulation of this RNA species in CEF expressing D184-C/EBPb and ts NY72-4 RSV at 378C, in agreement with the results of run-on transcription assays (Figure 5b ).
C/EBPb is not required for the transformation of CEF by pp60 v-src
During the course of these studies, it became clear that NY72-4 RSV CEF expressing the dominant negative mutant D184-C/EBPb had a proliferative advantage over the control cells or uninfected CEF (our unpublished observations). In addition, D184-C/EBPb did not impair the transformation of CEF by pp60 v-src . Indeed, CEF expressing the dominant negative mutant were more refractile at the permissive temperature depicting the rounded morphology of highly transformed cells (compare b and d for RCASBP/72-4 RSV and RCASBP-D184-C/EBPb /72-4 RSV, respectively; Figure 7 ). Finally, the same NY72-4 RSV-transformed CEF expressing the dominant negative mutant of C/ EBPb were able to form colonies in soft agar of similar size and at the same frequency as CEF infected solely by NY72-4 RSV (Figure 7e,f) . Therefore, the transformation of CEF by pp60 v-src in vitro is not dependent on the activation of C/EBPb.
Discussion

C/EBPb is required for the activation of the CEF-4 SRU
We have identi®ed C/EBPb as the CAAT binding factor of the CEF-4 SRU in RSV-transformed CEF (Figure 2) . We showed that C/EBPb binds to two separate elements of the SRU and that both of these elements are required for the v-src dependent activation of the promoter (Figures 1 and 2 ). Thus we have now identi®ed three dierent transcription factors responsible for the transcriptional activation of CEF-4. In addition to C/EBPb, AP-1 and NF-kB are also involved in this process. In RSV-transformed CEF, AP-1 is composed predominantly of the JunD/Fra-2 heterodimer with c-Jun/Fra-2 present as a minor component (our unpublished results). PRDII is bound by p50NF-kB1 and an unidenti®ed IkBa-sensitive protein, which is not c-Rel (Cabannes et al., 1997) . Synergism between AP-1, NF-kB and C/EBPb (NF-IL6) has been described for various promoters including that of the IL-8, serum amyloid A and TSG-6 genes (Klampfer et al., 1994; Matsusaka et al., Figure 6 Northern blotting analyses of mRNAs for v-src regulated genes in CEF co-infected with RCASBP and ts NY72-4 RSV (lanes B) or RCASBP-D184 and ts NY72-4 RSV (lanes m). RNA was isolated from doubly infected cells maintained at the non permissive temperature (time 0) or transferred to the permissive temperature for 1, 10 or 24 h Components of these factors interact with each other and several co-activators, assembling in the process a more potent transcriptional activation complex (Chang et al., 1998; LeClair et al., 1992; Merika et al., 1998; Mink et al., 1997; Stein et al., 1993) . Synergism also appears to be required for the activation of the CEF-4 promoter in RSV-transformed CEF (Figure 1 ; . The accumulation of the Cox-2 mRNA was also impaired by the dominant negative mutant. While a role for C/EBPb in the v-src dependent activation of this gene has not been described in murine ®broblasts, the Cox-2 promoter harbors two C/EBP binding sites which are required for transcriptional activation in response to other stimuli in macrophages and mouse skin carcinoma cells (Kim and Fisher, 1998; Wadleigh et al., 2000) . Since the eects of D184-C/EBPb were transient in CEF and only observed in the ®rst hour following the activation of the thermolabile by pp60
v-src , this may explain why C/EBPb has not been identi®ed previously as a critical factor in the v-src dependent activation of this gene. Factors targeting the CRE are involved in the activation of Cox-2 by pp60 v-src in murine ®broblasts (Xie et al., 1994) .
It is perhaps surprising that the dominant negative mutant of C/EBPb did not completely suppress the activity of the CEF-4 promoter when expressed in a retroviral vector ( Figure 5 ). In contrast, the mutation of both C/EBPb binding sites of the SRU abolished the activation by pp60 v-src (Figure 1b ). This discrepancy may indicate that these elements are also targeted by an unrelated transcription factor, which remains to be identi®ed. However, the results of antibody supershift con®rmed that nearly all complexes of the distal and proximal CAAT boxes were aected by the C/EBPb antibody (Figure 2a,b) . Since the interaction with Jun and NF-kB members only depends on the leucine zipper of C/EBPb LeClair et al., 1992; Stein et al., 1993) , an intriguing possibility is that the dominant negative mutant is still capable of interacting and cooperating with other factors of the SRU (Zagariya et al., 1998) . However, the decrease in CEF-4 transcription and mRNA levels implies that the dominant negative mutant did interfere with the activation of C/EBP-controlled genes by pp60 v-src (Figures 5 and 6) .
Two proteins of 42 kDa and 38 kDa of molecular weight were recognized by the C/EBPb antiserum (Figure 3a) . These proteins most likely represent dierent isoforms generated by the utilization of multiple translation initiation sites present in the C/ EBPb mRNA (Calkhoven et al., 1994; Kowenz-Leutz and Leutz, 1999; Timchenko et al., 1999) . The predominant form observed in CEF and expressed by the recombinant C/EBPb retrovirus is the 42 kDa protein. The N-terminus of this isoform interacts directly with the Swi/Snf nucleosome remodeling complex and is the most potent form of C/EBPb in transcription activation . Using antibodies for mammalian C/EBPb, Sears and Sealy (1994) described proteins with a similar molecular weight in CEF (42 ± 38 and 35 kDa). These investigators provided evidence that the C/EBPb isoforms generate multiple dimers interacting with the EFII enhancer sequence of the RSV LTR. Sears and Sealy also reported the existence of a 20 kDa isoform corresponding to LIP in nuclear extracts of CEF. However, we failed to detect a low molecular form of this protein by Western blotting analysis. Since D184-C/EBPb was recognized by our antiserum (Figure 4a) , these results do not re¯ect the inadequacy of our antibody. The discrepancy between our results and those of Sears and Sealy may stem from dierences in experimental approaches.
C/EBPb, a transcription factor regulated by reversible growth arrest and by pp60 The results of proliferation assays and growth in soft agar revealed that C/EBPb is not required for CEF transformation by pp60 v-src . In fact, the expression of the dominant negative mutant D184-C/EBPb enhanced morphological transformation, CEF proliferation and the induction of the v-src regulated gene NR-13 (Figures 6 and 7 and data not shown), suggesting an inhibitory function for the C/EBP family in CEF proliferation. In agreement with this notion, we recently described the activation of the p20K lipocalin gene by C/EBPb (Kim et al., 1999) . p20K is expressed in serum-starved or contact-inhibited CEF and therefore is a marker of reversible growth-arrest in these cells (Bedard et al., 1987b; Mao et al., 1993) . C/EBPb is expressed in several tissues and cell types where it controls cell fate and dierentiation. Primary keratinocytes isolated from C/EBPb de®cient mice have an altered pattern of growth arrest and dierentiation in vitro (Zhu et al., 1999) . Moreover, these animals are characterized by mild epidermal hyperplasia, consistent with a role for C/EBPb in growth arrest and early cell dierentiation. In in vitro models of adipocyte dierentiation, C/EBPb activates the expression of C/ EBPa, which inhibits cell proliferation by p21Waf1 dependent and independent mechanism (Muller et al., 1999; Timchenko et al., 1996) . Thus in this system, the inhibitory action of C/EBPb may be indirect. In our experimental system, the dominant negative mutant interferes with the activity of all interacting partners and therefore we cannot exclude the possibility that the inhibition of CEF proliferation is determined by a C/ EBP member other than C/EBPb.
Compelling evidence also indicates that C/EBPb is required for the proliferation of several cell types. C/ EBPb de®cient mice show defects in epithelial cell proliferation in the mammary gland and have a restricted liver regeneration capacity following partial hepatectomy (Greenbaum et al., 1998; Robinson et al., 1998; Seagroves et al., 2000) . More recently, Buck and co-workers demonstrated that hepatocytes from C/ EBPb (7/7) mice do not respond to mitogenic stimulation by TGFa (Buck et al., 1999) . Moreover, these authors showed that the phosphorylation and potentiation of C/EBPb transcriptional activity by pp90 RSK Oncogene Activation of CEF-4/9E3 by C/EBPb M Gagliardi et al is required for the stimulation of hepatocyte proliferation by TGFa. Therefore, C/EBPb appears to be a versatile regulator of growth control. The mechanisms underlying this dual activity are still poorly understood but may depend on translational control and dierences in the expression of the various C/EBPb isoforms (Calkhoven et al., 2000) . Translational induction of the 20 kDa dominant negative mutant form, known as LIP, is correlated with transformation in mammary epithelial cells (Raught et al., 1996) . More recently, Calkhoven et al. (2000) reported that the over-expression of LIP induces transformation in 3T3-L1 adipocytes. In normal and RSV-transformed CEF, LIP is not detectable (Figure 3) . Since the 42 and 38 kDa forms predominate, our results support the notion that these isoforms promote growth arrest in CEF. In this respect, the action of the dominant negative mutant may account for the accentuated phenotype of v-src transformed CEF (Figure 7) , the stimulation of NR-13 mRNA accumulation in these cells ( Figure 6 ) and possibly the stimulation of the TRE construct in transient expression assays (Figures  1b and 5a ).
C/EBPb and v-src transformation
Chemokines act as autocrine factors for a number of transformed cell lines and in particular for melanoma and glioma cells (Balentien et al., 1991; Richmond et al., 1988; Schadendorf et al., 1993) . More often though, it is thought that chemokines function in a paracrine fashion to regulate a variety of biological processes including wound healing and tumor formation. Thus, the angiogenic and pro-in¯ammatory activities of chemokines enhance tumorigenesis by promoting tumor vascularization and tissue invasion as a result of protease over-production (Arenberg et al., 1996; Haghnegahdar et al., 2000; Koch et al., 1992; Sunderkotter et al., 1994; Wakabayashi et al., 1995; Yoshida et al., 1997) . While we clearly demonstrated that C/EBPb was dispensable for v-src transformation of CEF in vitro (Figure 7 ), the role of this factor and the CEF-4 chemokine has yet to be examined in tumor formation. We also observed that the D184-C/EBPb dominant negative mutant reduced the expression of gag proteins, a result consistent with a role for C/EBPb in the stimulation of the RSV LTR (our unpublished results, Sears and Sealy, 1992) . This eect did not interfere signi®cantly with viral replication in CEF cultured in vitro but may be deleterious in less favorable conditions and particularly in tumors. In this respect, C/EBPb may act as an essential factor of RSV propagation in vivo. Starvation of RSV-transformed CEF causes a rapid induction in the synthesis of the quiescence-speci®c p20K lipocalin, a phenomenon which may re¯ect the rapid depletion of essential nutrients by transformed cells (Mao et al., 1993) . However, the abrupt induction of p20K is also likely to re¯ect the activation of C/EBPb in RSV-transformed CEF. We have recently determined that C/EBPb controls the expression of most, if not all, quiescence-speci®c proteins previously identi®ed in CEF (Bedard et al., 1987b and manuscript in preparation) . There is increasing evidence suggesting that G 0 -regulated genes are part of a survival or adaptative response to deleterious growth conditions (Kim et al., 1999) . An intriguing possibility is that pp60 v-src regulates the expression of G 0 -speci®c genes through C/EBPb and by doing so promotes cell survival. Clearly, a proper assessment of the signi®cance of C/EBPb activation will require the study of animal models of v-src tumor formation and RSV replication in vivo.
Materials and methods
Cells and viruses
Early passages of chicken embryo ®broblasts (CEF) were cultured at 41.58C in Richter-improved minimal medium containing insulin and zinc (I + medium, Irvine Scienti®c, Santa Ana, CA, USA), 5% heat-inactivated newborn serum (MediaserII, Montreal Biotech Inc., Kirkland, QC, Canada), 5% tryptose phosphate broth, glutamine, penicillin and streptomycin. CEF were infected with the Schmidt-Ruppin A strain of the Rous sarcoma virus (SR-A RSV), the ts mutant NY 72-4, or with recombinant viruses generated with the RCASBP(A) or RCASBP(B) retroviral vectors.
Soft agar assays
Soft agar assays were carried out in 60 mm dishes containing a lower layer of 0.7% agar in I + medium containing 30% fetal calf serum, 4% chicken serum, 10% tryptose phosphate broth, antibiotics and glutamine. Ten thousand cells, suspended in the same medium containing 0.35% agar, were overlayed on the bottom layer and incubated at 378C for 5 days.
Nuclear run-on transcription assays, Northern blotting and RT ± PCR analyses Run-on transcription assays were performed as described previously with the modi®cation that nuclei were isolated from 4610 7 cells and resuspended in a transcription buer containing 300 mCi of [a-32 P]UTP. Labeled transcripts were hybridized to 2 mg of linearized Bluescript SK + plasmid (as a negative control) or plasmids harboring the avian C/EBPa, C/EBPb, CEF-4 or glyceraldehyde phosphodehydrogenase (GAPDH) cDNA blotted onto NYTRAN membranes (Schleicher and Schuell). The intensity of radioactive bands on blots was quantitated with an InstantImager (Packard/Canberra). Northern blotting analysis was performed as described before (Bedard et al., 1987a) . Brie¯y, 7.5 mg of total RNA were loaded per lane and separated on a 1% agarose gel containing formaldehyde. The RNA was transferred onto NYTRAN membranes and probed with a radiolabeled cDNA for genes of interest. For RT ± PCR analysis, 10 mg of total RNA from uninfected (normal) and SR-A RSV-transformed CEF were treated with DNAse I (RQ1 DNAse; Promega) for 15 min and then reverse transcribed after inactivation of the DNAseI at 658C for 10 min. Reverse transcription was performed with genespeci®c primers for C/EBPb (5'-GCCGGCGGCCGACTTG-3') and GAPDH (5'-GAGACAGAAGGGAAC-3') in the Activation of CEF-4/9E3 by C/EBPb M Gagliardi et al presence or absence of reverse transcriptase (recombinant MuLV RTase, New England Biolabs) for 1 h at 378C. DNA ampli®cation reactions were performed using 1 ml of the reverse transcriptase reaction and Vent thermostable polymerase (New England Biolabs) using the following pairs of primers: C/EBPb: 5' primer: 5'-TTTGCTTTCATG-CAACGCCTG-3'; 3' primer: 5'-GCCGCCGCTGCCTTTA-TA-3'; GAPDH: 5' primer: 5'-GTCGGAGTCAACGGATT-3'; 3' primer: 5'-GAAGAATGGCTGTCACC-3'. DNA ampli®cation was performed for 20 cycles, the products of which were analysed on 1.5% agarose gel and visualized by ethidium bromide staining. The identity of the C/EBPb and GAPDH DNA fragments (356 and 846 bp in size, respectively) was con®rmed by Southern blotting analysis with the corresponding radioactive cDNAs used as probes.
Promoter and expression constructs
Constructs of the CEF-4 promoter fused to the chloramphenicol acetyltransferase gene (CAT gene) are depicted in Figure 1 , some of which have been described previously . Brie¯y, plasmid SPE/CAT includes nucleotides 7214 to +36 of the 5'¯anking and transcribed region of the CEF-4 gene and contains the intact v-src responsive unit (SRU). APC/CAT was generated by inserting a synthetic double stranded oligonucleotide corresponding to nucleotides 7119 to 764 of the CEF-4 promoter into the internally deleted S-N/CAT construct at the site of deletion. Mutations in the CAAT boxes of the CEF-4 promoter were generated using the QuikChange site directed mutagenesis kit (Stratagene, La Jolla, CA, USA). The sequence of the oligonucleotide primers for the proximal and distal CAAT elements is as follows: mpCAAT/CAT(+):5'-CTGGGAAATTCCTCTAACTAGTT-TACATGCTAGCATAGCTCTGC-3'; mpCAAT/CAT(7): 5'-GCA GAGCTATGCTAGCAT GTAAACTAGTTAGAG-GAATTTCCCAG-3'; mdCAAT/CAT(+):5'-CATCATCAG-CTAGTCTAGTCGACAACAGTCATGTGACTC-3'; mdC-AAT/CAT (7) :5'-GAGTCA CATGAC TGTTGTCGACTA-GACTAGCTGATGATG-3'. The underlined sequence indicates sequences that were mutated in the CAAT elements of the CEF-4 promoter which abrogate C/EBP binding activity and create a new SpeI and SalI site for the identi®cation of mutant promoter constructs mpCAAT/CAT and mdCAAT/ CAT, respectively. The m(d+p)CAAT/CAT plasmid was constructed by repeating the site directed mutagenesis protocol using the mpCAAT/CAT(+/7) oligonucleotide primers with the mdCAAT/CAT plasmid as a template. To generate multimeric distal CAAT, proximal CAAT and TPAresponsive element (TRE) minimal promoter constructs, synthetic double stranded oligonucleotides representing these sites were cloned into the HindIII site of the plasmid pJFCAT/TAT which includes a TATAAA box and the initiation start site of the human b globin gene. Retroviral vectors were constructed by inserting the full length avian C/ EBPb cDNA or the dominant negative mutant D184-C/EBPb cDNA into the Cla12 adaptor plasmid followed by subcloning into the unique ClaI site of RCASBP(A) and RCABP(B). The resulting vector was transfected in CEF by the calcium phosphate precipitation method (Mao et al., 1993) and a productive infection was established by the replication-competent avian retrovirus. D184-C/EBPb was isolated from the expression plasmid pCDM8-D184; the latter and its parental counterpart (pCDM8) were provided by Dr A Leutz (Katz et al., 1993) .
Transient expression assays
CEF were infected with ts NY72-4 or co-infected with ts NY72-4 RSV and RCASBP retroviral expression vectors. CEF were plated at a density of 2610 6 cells/100 mm dish 24 h prior to transfection. Transfections were performed at the non-permissive temperature (41.58C) by the DEAEDextran method described previously using a total of 20 mg of DNA consisting of 2.5 mg of reporter plasmid, 2 mg of the pRSV-b-gal and 15.5 mg salmon sperm carrier DNA. In experiments with expression plasmids, 10 mg of plasmid pCDM8 or pCDM8-D184 were included in the transfection mixture. For all transient expression assays, the activity of the CAT reporter enzyme was determined in lysates representing equal levels of b-galactosidase activity. All transfections were performed in duplicates or triplicates in at least two separate experiments. [ 14 C]Chloramphenicol and its acetylated derivatives were separated by thin layer chromatography and quantitated in an InstantImager (Packard/Canberra).
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts were prepared by a modi®cation of the methods of Briggs et al. (1986) and Dignam et al. (1983) . Routinely, 10 7 cells were washed once with cold PBS, collected for 5 min in a microcentrifuge at 1500 g and resuspended in 500 ml of buer A (consisting of 10 mM HEPES pH 7.9, 10 mM KCl, 0.5 mM DTT, 1.5 mM MgCl 2 , and a cocktail of proteases and phosphatase inhibitors consisting of 0.5 mM phenylmethyl sulfonyl¯uoride[PMSF], 0.3 mg leupeptin/ml, 0.3 mg antipain/ml, 0.5 mg aprotinine/ml, 1 mM sodium¯uoride and 1 mM sodium vanadate). Cells were lysed with a glass Dounce homogenizer (B pestle) and the nuclei were pelleted by centrifugation at 12 000 g for 20 min at 48C. The nuclear pellet was extracted with 1 ml of buer C (20 mM HEPES pH 7.9, 25% glycerol, 1.5 mM MgCl 2 , 0.42 mM KCl, 0.5 mM DTT, 1 mM EDTA, and protease/phosphatase inhibitors as mentioned above) for 20 min at 48C with continuous agitation. At the end of the incubation, the reaction mixture was centrifuged at 12 000 g for 20 min and the supernatant dialyzed against buer D (20 mM HEPES pH 7.9, 20% glycerol, 0.1 M KCl, 0.5 mM DTT, 0.2 mM EDTA, and protease/phosphatase inhibitors) for 5 h at 48C. Protein concentration was determined by the Bradford assay using BSA as a standard. Synthetic DNA oligomers used for DNA binding analysis are shown below. Lower case letters indicate mutations introduced in the sequence. The wild type NF-M oligo is a composite of the two C/EBPb (NF-M) binding sites of the cMGF promoter (chicken myelomonocytic growth factor; Kim et al., 1999; Sterneck et al., 1992) ; dCAAT: 5'-TCGACTTGTGAAATG; 3'-GAACACTTTACAGCT-5'; mdCAAT: 5'-TCGACTTGTGAgtTG-3'; 3'-GAACACTcaACAGCT-5'; pCAAT: 5'-ACG-CGTAACGCAATTACATGA-3'; 3'-ATTGCGTTAATG-TACTGCGCA-5'; wt NF-M: 5'-TCGACACAATGAGGC-AAC-3'; 3'-GTGTTACTCCGTTGAGCT-5'; TRE: 5'-AGC-TTGTGACTCATTT-3'; 3'-ACACTGAGTAAACTAG-5'.
All probes were generated by ®lling in the ends with Klenow using [a-32 P]dCTP and unlabeled dGTP, dATP, and dTTP. Binding reactions were performed in a total volume of 20 ml of 16binding buer (20 mM Tris-HCl pH 7.5, 1 mM MgCl 2 , 60 mM NaCl and 5% glycerol) for 30 min at room temperature. For mobility shift assays, the radiolabeled oligonucleotides (approximately 10 000 c.p.m./0.1 ng) were incubated with 2 ± 5 mg of nuclear extracts in the presence of 2 mg of poly(dI-dC). Competition binding reactions were performed by pre-incubating the nuclear extract with an excess of unlabeled, ®lled in oligonucleotides for 15 min at room temperature followed by an additional 30 min incubation with radiolabeled oligonucleotides. The DNA-protein complexes were resolved on 4.2% non-denaturing polyacrylamide gels in 0.56TBE buer and visualized by autoradiography.
Western blotting analysis and production of C/EBPb antiserum Total cell protein extracts (40 mg) were prepared in SDS sample buer, subjected to SDS-polyacrylamide gel electrophoresis and blotted on nitrocellulose (BA85; Schleicher and Schuell). C/EBPb antiserum was generated using a recombinant avian C/EBPb protein as an antigen and established immunization protocols (Bedard et al., 1987b) . Antiserum for immunized rabbits was subsequently anity puri®ed and used at a dilution of 1 : 500 in a 5% solution of milk dissolved in PBS. This was followed by incubation with a peroxidase-conjugated secondary antibody (Pierce, Rockford, IL, USA) and revelation with a chemiluminescent substrate according to protocols provided by the manufacturer (ECL, Amersham). Antibody for ERK-1 (SC-93) was obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Immunofluorescence analysis
Immuno¯uorescence analysis was performed according to the experimental procedures outlined previously (Cabannes et al., 1997) with the following modi®cations. CEF ®xed onto coverslips and permeabilized were incubated with a 1 : 100 dilution of anity puri®ed C/EBPb antibody followed by an incubation with a¯uorescein-conjugated secondary antibody at a dilution of 1 : 70. Both primary and secondary antisera were diluted in a solution of PBS containing 10% fetal calf serum.
